HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA
CLINICAL TRIALS, STUDIES, REGISTRIES, DATA
Clinical trials, studies, data, and updates reported in Medical Device News Magazine.
Publication of COMPASS Study Validating First Scoring Guidelines for WatchPAT™ Device in Diagnosing Sleep Apnea
The COMPASS Study appears online in the Journal of Clinical Sleep Medicine.
Breakthrough Study Published Measuring the Effect of EOTTS to Reduce Medial Knee Compartment Forces
GraMedica reports, the first of its kind, the study measured the in vivo forces acting within the medial knee compartment, before and after EOTTS.
BD Completes Clinical Trial for BD Libertas Wearable Injector Completed
The award-winning Libertas Wearable Injector is a subcutaneous drug delivery system, currently in development, that is designed to require no patient assembly and deliver biologics with viscosities up to 50 cP in 2-5 mL and 5-10 mL configurations.
BrainsWay Announces Data from Feasibility Study of Deep Transcranial Magnetic Stimulation System
BrainsWay advises the results showed a statistically significant improvement in patient-reported assessments of inattention, together with a significant increase in activity that was observed within the dorsolateral prefrontal cortex, a brain area previously shown to express reduced activity in adults with ADHD.
DynaNail Mini Fusion System for Subtalar Fusion Procedures Shows Positive Early Results
The DynaNail Mini Fusion System has been implanted by over 50 orthopedic surgeons in over 50 hospitals across the United States.
Use of the Accuray TomoTherapy System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
Patients enrolled in the two studies received simultaneous daily radiation and a targeted radiation boost over a 25-day time period. The study investigators found that the TomoTherapy System unique architecture enabled the delivery of a high dose of radiation, directly to the tumor, through the integrated boost of radiation, while minimizing radiation to organs in close proximity to the targeted tumor.
Enrollment of the VasQ External Support US Pivotal Study Now Complete
VasQ is designed to address both the hemodynamic and mechanical factors associated with AVF failure.
SELUTION SLR Sirolimus Drug Eluting Balloon for Endovascular Applications Receives CE Approval: Award Supported by 2 Year Results from the SELUTION SLR First-in-Human Study...
This award was supported by two-year results from the SELUTION SLR First-in-Human study, involving 50 patients enrolled across four German centres.